Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection

Triple-negative breast cancer (TNBC) is a heterogeneous disease that can be classified into distinct molecular subtypes by gene expression profiling. Considered a difficult-to-treat cancer, a fraction of TNBC patients benefit significantly from neoadjuvant chemotherapy and have far better overall su...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:PLoS One
Päätekijät: Lehmann, Brian D., Jovanović, Bojana, Chen, Xi, Estrada, Monica V., Johnson, Kimberly N., Shyr, Yu, Moses, Harold L., Sanders, Melinda E., Pietenpol, Jennifer A.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Public Library of Science 2016
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4911051/
https://ncbi.nlm.nih.gov/pubmed/27310713
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0157368
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia